Curis
CRIS
#10175
Rank
โ‚ฌ12.07 M
Marketcap
0,88ย โ‚ฌ
Share price
0.00%
Change (1 day)
-63.60%
Change (1 year)

Revenue for Curis (CRIS)

Revenue in 2025 (TTM): โ‚ฌ10.45 Million

According to Curis's latest financial reports the company's current revenue (TTM ) is โ‚ฌ10.14 Million. In 2024 the company made a revenue of โ‚ฌ10.48 Million an increase over the revenue in the year 2023 that were of โ‚ฌ9.06 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Curis from 2001 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ10.45 M-0.28%
2024 โ‚ฌ10.48 M15.61%
2023 โ‚ฌ9.06 M-4.29%
2022 โ‚ฌ9.47 M0.75%
2021 โ‚ฌ9.4 M6.74%
2020 โ‚ฌ8.8 M-1.36%
2019 โ‚ฌ8.93 M-2.03%
2018 โ‚ฌ9.11 M10.5%
2017 โ‚ฌ8.24 M15.28%
2016 โ‚ฌ7.15 M-0.69%
2015 โ‚ฌ7.2 M-10.97%
2014 โ‚ฌ8.09 M-25.49%
2013 โ‚ฌ10.86 M-15.33%
2012 โ‚ฌ12.83 M12.87%
2011 โ‚ฌ11.36 M-5.5%
2010 โ‚ฌ12.02 M100.62%
2009 โ‚ฌ5.99 M0.18%
2008 โ‚ฌ5.98 M-46.68%
2007 โ‚ฌ11.22 M-0.84%
2006 โ‚ฌ11.31 M17.72%
2005 โ‚ฌ9.61 M163.36%
2004 โ‚ฌ3.65 M-58.39%
2003 โ‚ฌ8.77 M-50.12%
2002 โ‚ฌ17.59 M1329.99%
2001 โ‚ฌ1.23 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚ฌ54.66 B 538,835.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.82 B 412,209.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚ฌ22.4 M 120.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚ฌ1.99 B 19,541.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ2.26 M-77.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.65 B 6,343.78%๐Ÿ‡บ๐Ÿ‡ธ USA